Our Company

We are a biotechnology and pharmaceutical strategy consulting company that combines detailed research with clear and thoughtful analysis. Our goal is to bring insight and perspective to clients to help them meet the demands of a complex marketplace. We have over 10 years of experience in analyzing cutting-edge technologies and their role in dynamic markets. Because we stay abreast of both technical and business developments in the industries of importance to our clients we are able to form teams that are ready to work with you with little or no learning curve. Whether you are an established company looking for new opportunities or an emerging player scoping out the competitive environment, BioPerspectives is the ideal partner to find real-world solutions to your key strategic questions.


Our Philosophy

At BioPerspectives we integrate science and business. We believe that our understanding and appreciation for the science behind the biotechnology and pharmaceutical industries is key to our success. Our understanding allows us to communicate clearly and effectively with clients to define their key problems. We balance our scientific understanding with in-depth knowledge of the industries and businesses in which our clients compete. This balance is critically important in order to provide meaningful insights that lead to workable real-world solutions.


Our Expertise

Steven Bodovitz, Principal, is an international authority on biotechnology. He has written more than 20 business plans, including one that led to a $70 million acquisition and another that led him to an offer to become CEO. In addition, he has written multiple reports and review articles, and he has interviewed hundreds of customers and potential customers. His honors include: (1) serving on the advisory boards of multiple conferences, in both the U.S. and Europe, (2) plenary speaker at Chips to Hits in 2004, (3) study section member for special RFA from the NIH, (4) featured as a Pioneer of Proteomics in ProteoMonitor, and (5) quoted in Nature Biotechnology twice and Science and The Economist once.


Working with us

Clients information needs vary, therefore, we offer products and services to meet different information and budget requirements:

• We offer small business services that are ideally suited for those needing cost-effective support for business plan and strategy development
  
• We conduct primary research on a custom consulting basis to answer your specific strategic questions
  
• We publish strategic reports that integrate market and technical analysis of emerging technologies and therapeutic areas

Our Clients

BioPerspectives’ clients include the following industry leading and emerging companies in the U.S., Europe and Japan:

Affymetrix
AminoArrays
Agilent Technologies
Applied Biosystems
Axela Biosensors
GE Healthcare
IBM
Motorola Life Sciences
Platypus Technologies
Roche Diagnostics
Samsung Corporation
UBS
Vivo Biosciences
Yokogawa
Zeptosens